For one, the technology has helped Alaska Airlines reduce aircraft turn times by 12% at its Seattle-Tacoma Airport hub.
The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback